466 results
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...
Innovation and imaging guidance for tricuspid valve replacement
21 Nov 2021 – From PCR London Valves
Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
Unusual situations in valvular interventions
21 Nov 2021 – From PCR London Valves 2021
Let's discover an electrosurgical removal of an entrapped central venous catheter, witness a coronary extra-adventitial hematoma complication of transcatheter tricuspid annuloplasty, and appreciate buddy balloon technique as bailout strategy during RVOT stent embolization, among others, in this special PCR London Valves 2021 session dedicated to unusual...
Right-side THV implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to learn more about tricuspid valve-in-ring for severe symptomatic tricuspid regurgitation, to consider the transcatheter heart valve for isolated tricuspid regurgitation, and to see an unresolved complication in transcatheter tricuspid ViV, among others.
A heart-team discussion for tricuspid valve intervention
21 Nov 2021 – From PCR London Valves 2021
Join Vinayak Bapat, Joao Cavalcante and Paul Sorajja to learn about how the heart-team approaches tricuspid valve intervention, how to pre-procedurally plan transcatheter tricuspid valve repair/replacement and how to intra-operatively guide TTVR using imaging.
State-of-the-art: Transcatheter treatment for tricuspid valve disease
19 Nov 2021
The development and successful results of transcatheter aortic valve implantation, followed by transcatheter therapies for mitral valve disease have opened a myriad of opportunities for transcatheter treatment of TR. Read this State-of-the-Art paper published in EuroIntervention by the PCR Tricuspid Focus Group.
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with TR - a written review
09 Nov 2021
The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.
Author
Author
